Philips, Bioscan partner on NanoSPECT marketing

AuntMinnieEurope.com staff writers
Jan 1, 2007

Philips Medical Systems has signed an agreement giving it the rights to co-market and co-distribute molecular imaging developer Bioscan's NanoSPECT and NanoSPECT/CT devices.

The agreement covers countries in Europe, the Middle East, Africa, Asia, and Latin America, according to Andover, MA-based Philips.

The Washington, DC-based Bioscan said it will continue to market and sell the NanoSPECT product line in the U.S., and will continue to focus on the biotechnology and pharmaceutical market segment in Europe and other parts of the world.

By AuntMinnie.com staff writers
January 2, 2007

Related Reading

Philips awarded Spanish contract, December 19, 2006

Philips RSNA highlights include MRI, DR, SPECT introductions, November 27, 2006

Philips unveils Wi-Fi asset tracker for healthcare, November 16, 2006

Road to RSNA, Philips Medical Systems, November 15, 2006

Philips debuts 4D transducer, November 14, 2006

Copyright © 2007 AuntMinnie.com

Latest in Molecular Imaging
Hyperparathyroidism 6723cbda6242a
PET/CT proves value in patients with hyperparathyroidism
November 4, 2024
3 D Rendered Pet Machine 400
New study highlights long-term benefits of PSMA-PET
October 28, 2024
Pet Scanner Bore
ESMIT highlights standout sessions for EANM 2024
October 18, 2024
Ge Health Care Logo
GEHC announces new theranostics center in Germany
October 16, 2024
More in Molecular Imaging
PET/CT proves value in patients with hyperparathyroidism
By Will Morton
A French group has reported that F-18 fluorocholine PET/CT appears to be an effective first-line imaging method in patients with primary hyperparathyroidism.
November 4, 2024
Hyperparathyroidism 6723cbda6242a
New study highlights long-term benefits of PSMA-PET
By Will Morton
Prostate-specific membrane antigen (PSMA) PET imaging can improve the length and quality of life for patients with recurrent prostate cancer, researchers have reported.
October 28, 2024
3 D Rendered Pet Machine 400
ESMIT highlights standout sessions for EANM 2024
By AuntMinnieEurope.com staff writers
The European School of Multimodality Imaging and Therapy (ESMIT) has given advice to attendees ahead of the annual congress of the European Association of Nuclear Medicine (EANM) in Hamburg, Germany.
October 18, 2024
Pet Scanner Bore
GEHC announces new theranostics center in Germany
By AuntMinnieEurope.com staff writers
GE HealthCare (GEHC) is collaborating with University Medicine Essen in Germany to establish a new Theranostics Center of Excellence.
October 16, 2024
Ge Health Care Logo
New guidelines cover theranostics for brain tumors
By Will Morton
The use of somatostatin receptor PET imaging and therapy in meningiomas is on the rise, and new recommendations can help pave the way to improved outcomes for patients.
October 16, 2024
Brain
Swiss overcome logistical issues in clinical audits
By Edna Astbury-Ward, PhD
Clinical audits in radiation protection are proving valuable in Switzerland, but serious challenges have arisen due to the country's four official languages and diverse regional cultures.
September 26, 2024
Radiation Symbol Word Cloud Thumbnail
Targeted prostate therapy displays clinical promise
By Will Morton
An emerging radiopharmaceutical treatment seems to perform as effectively in prostate cancer patients in “real-world” settings as it did in clinical trials prior to its approval.
September 25, 2024
Benign Prostatic Hyperplasia
Microplastics reach the olfactory bulb in the human brain
By Will Morton
Researchers have detected microplastics in olfactory bulb brain tissues of eight deceased individuals, and they suggest MRI could be the next step for studying the effects of the pollutants on human health.
September 23, 2024
Olfactory Bulb Brain
Radiotracer for kidney cancer performs well in phase III trial
By Will Morton
A PET radiotracer that detects clear-cell renal cell carcinoma proved safe and highly effective in a clinical trial conducted at 36 research hospitals across nine countries.
September 13, 2024
Pet Renal Cancer 66e1e00428375 Thumbnail
Mevion, Nelco to partner on proton therapy
By AuntMinnieEurope.com staff writers
Mevion Medical Systems and Nelco Worldwide are collaborating on the faster adoption of proton therapy.
September 13, 2024
Mevion Astro 2019
PET/MRI shows promise in patients with large vessel vasculitis
By Will Morton
PET/MRI could be an invaluable tool for evaluating how patients with large vessel vasculitis respond to treatments, a new study has found.
August 30, 2024
2024 08 25 Natcomms Pet Mri Treatment Response Lvv Pugh Thumbnail
FDG-PET scans can help predict risk of dementia
By Will Morton
A normal brain F-18 FDG-PET scan can rule out the short-term risk of dementia in older patients who present with cognitive complaints.
August 21, 2024
2024 08 13 Alztherapy Fdg Pet Rules Out Ad Heyer Image
Page 1 of 117
Next Page